AddBIO Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $202K
Latest Deal Amount
  • Investors
  • 7

AddBIO General Information

Description

Developer of a bisphosphonate drug coating created to give local bones a strengthening effect to enhance implant stability. The company's nanolayer is a thin layer of a blood protein and fully biocompatible to improve the bone holding power, thus enabling healthcare organizations to provide a better implant experience to patients with better results and faster recovery.

Contact Information

Website
www.addbio.se
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Biotechnology
Primary Office
  • Teknikringen 10
  • 583 30 Linköping
  • Sweden
+46 013-21 00 00

AddBIO Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AddBIO Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 01-Apr-2020 $202K 00.000 Completed Generating Revenue
7. Later Stage VC 01-Dec-2018 00000 00.000 Completed Generating Revenue
6. Later Stage VC 01-Mar-2018 00.000 00.000 Completed Generating Revenue
5. Later Stage VC 01-Dec-2016 00.000 00.000 Completed Generating Revenue
4. Debt - General 01-May-2016 00000 00.000 Completed Generating Revenue
3. Secondary Transaction - Private 01-Mar-2015 00.000 Completed Generating Revenue
2. Later Stage VC 17-Apr-2012 $1.07M $1.07M Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view AddBIO’s complete valuation and funding history, request access »

AddBIO Executive Team (8)

Name Title Board Seat Contact Info
Ulf Sewerin Chief Executive Officer
Lotta Tegler Chief Technology Officer
Pentti Tengvall Ph.D Co-Founder & Advisor
Anders Weilandt Chairman
You’re viewing 4 of 8 executive team members. Get the full list »

AddBIO Board Members (13)

Name Representing Role Since
Anders Weilandt Self Chairman 000 0000
Gunilla Lundmark Self Board Member 000 0000
Henrik Rammer AddBIO Board Member 000 0000
Lars Henriksson AddBIO Board Member 000 0000
Pär-Olov Östman AddBIO Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

AddBIO Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AddBIO Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Vinnova Government Minority 000 0000 000000 0
Berinor Corporation Minority 000 0000 000000 0
Henrik Rammer Angel (individual) Minority 000 0000 000000 0
Tommy Johansson Angel (individual) Minority 000 0000 000000 0
Almi Invest Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »